Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Evaluation of impact of Mirabegron on erectile function for patients treated for BPH
50 patients (Group A) will receive Mirabegron & alpha blocker 50 patients (Group B) will receive alpha blocker only Evaluation using IIEF 5 scoring system
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group A Mirabegron | 50 patients receiving Mirabegron 50 mg once daily & alpha blocker |
| |
| Group B alpha blocker only | 50 patients receiving alpha blocker only |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Mirabegron 50 MG | Drug | Mirabegron 50 mg daily dose and follow Up of erectile function using international index of erectile function 5 scoring system |
|
| Measure | Description | Time Frame |
|---|---|---|
| Impact of Mirabegron on erectile function | Using international index of erectile function 5 score system , least score 5 means severe erectile dysfunction and highest score 25 means no erectile dysfunction | 6 months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
All males above age of 50 with LUTS due to BPH
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| C520025 | mirabegron |
| D000317 | Adrenergic alpha-Antagonists |
| ID | Term |
|---|---|
| D018674 | Adrenergic Antagonists |
| D018663 | Adrenergic Agents |
| D018377 | Neurotransmitter Agents |
| D045504 | Molecular Mechanisms of Pharmacological Action |
Not provided
Not provided
Not provided
Not provided
Not provided
| Alpha Blockers | Drug | Alpha blocker daily and evaluation of erectile function using international index of erectile function 5 scoring system |
|
| D020228 | Pharmacologic Actions |
| D020164 | Chemical Actions and Uses |
| D045505 | Physiological Effects of Drugs |